Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0350 (5%) ($7.0350 - $7.0350) on Tue. Aug. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.23% (three month average) | RSI | 47 | Latest Price | $7.0350(5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) EDOC(38%) XBI(31%) GLD(20%) VIXM(20%) BND(18%) | Factors Impacting BCRX price | BCRX will decline at least -1.615% in a week (0% probabilities). XLRE(-43%) XLP(-37%) SPLV(-28%) DIA(-25%) XLI(-24%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.615% (StdDev 3.23%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.31 | 5 Day Moving Average | $7.1(-0.92%) | 10 Day Moving Average | $7.3(-3.63%) | 20 Day Moving Average | $7.31(-3.76%) | To recent high | -20.6% | To recent low | 5% | Market Cap | $1.241b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |